2023
DOI: 10.1016/j.mce.2023.111908
|View full text |Cite
|
Sign up to set email alerts
|

Treatment with bergamot (Citrus bergamia) leaves extract attenuates leptin resistance in obese rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 27 publications
0
1
0
Order By: Relevance
“…Regarding the role of bergamot derivatives and byproducts on metabolic disorders, it was seen that a bergamot leaf extract (BLE) is able to decrease inflammation (TNF-α and IL-6 levels) and oxidative stress, acting on the adipose tissue–liver axis of obese rats, with an effect which might improve both insulin resistance and dyslipidemia conditions [ 85 ]. In the same experimental model, BLE was also studied at the hypothalamic level, where it reduced the inflammation (decreasing the production of cytokine signaling (SOCS) 3, IL-6 and TNF-α and activating the JAK2/STAT3 pathway) and oxidative stress, thus counteracting the resistance to leptin (known as the “satiety hormone”) of obese rats [ 86 ]. Clinically, a nutraceutical containing bergamot extract was shown to improve systemic inflammation, significantly reducing high-sensitivity C-reactive protein (hs-CRP) and TNF-α levels in dyslipidemic overweight subjects [ 87 ].…”
Section: Anti-inflammatory Activity Of Bergamot Derivatives and Bypro...mentioning
confidence: 99%
“…Regarding the role of bergamot derivatives and byproducts on metabolic disorders, it was seen that a bergamot leaf extract (BLE) is able to decrease inflammation (TNF-α and IL-6 levels) and oxidative stress, acting on the adipose tissue–liver axis of obese rats, with an effect which might improve both insulin resistance and dyslipidemia conditions [ 85 ]. In the same experimental model, BLE was also studied at the hypothalamic level, where it reduced the inflammation (decreasing the production of cytokine signaling (SOCS) 3, IL-6 and TNF-α and activating the JAK2/STAT3 pathway) and oxidative stress, thus counteracting the resistance to leptin (known as the “satiety hormone”) of obese rats [ 86 ]. Clinically, a nutraceutical containing bergamot extract was shown to improve systemic inflammation, significantly reducing high-sensitivity C-reactive protein (hs-CRP) and TNF-α levels in dyslipidemic overweight subjects [ 87 ].…”
Section: Anti-inflammatory Activity Of Bergamot Derivatives and Bypro...mentioning
confidence: 99%
“…In the 20th week, when hypertriglyceridemia (C: 93.0 ± 38.2 vs. HSF: 139.5 ± 69.7, p < 0.001) and insulin resistance (C: 3.8 ± 0.9 vs. HSF: 5.5 ± 1.3, p < 0.001) were detected in the HSF group, a separation point (SP) was adopted once animals exposed to different diet models did not always present the expected response [19,21]. After that, the control and HSF groups of animals, above and below the SP, respectively, were excluded from the experiment.…”
Section: Experimental Protocol and Group Characterizationmentioning
confidence: 99%
“…The consumption of the chow and water of each animal were measured weekly, and the caloric intake was determined by multiplying the energy value of each diet (g × Kcal). The epididymal, visceral and retroperitoneal fat deposits were dissected during euthanasia and used as a sign of obesity using the adiposity index determination, following the formula: Adiposity index = [(Epididymal fat + Visceral fat + Retroperitoneal fat)/final body weight] × 100 [21,22].…”
Section: Analysis Of Nutrition and Metabolismmentioning
confidence: 99%